Clinical Trial Update: Study GSI-136 in Healthy Young and Healthy Elderly Subjects [Phase 1]

View source ↗

Summary

Phase 1 study of GSI-136 in healthy young and elderly subjects has completed; Wyeth (Pfizer) sponsored the trial, which lists Alzheimer's disease among the cond…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• GSI-136 (GSI-136)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Alzheimer Disease, Healthy | Phase 1 | Status: COMPLETED